Monogram Orthopaedics, Inc. (MGRM)
USD 2.72
(-4.56%)
USD 2.72
(-4.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -13.54 Million | -8.41 Million | -9.16 Million | -5.4 Million | -1.04 Million | -306.86 Thousand |
| Net Income | -13.74 Million | -13.69 Million | -11.81 Million | -9.06 Million | -1.79 Million | -712.26 Thousand |
| Depreciation & Amortization | 412.33 Thousand | 386.68 Thousand | 321.98 Thousand | 95.69 Thousand | 31.76 Thousand | 30.95 Thousand |
| Deferred income taxes | -13.2 Million | 3.43 Million | 1.56 Million | - | -694.02 Thousand | - |
| Stock-based compensation | 1.55 Million | 743.27 Thousand | 205.62 Thousand | 2.16 Million | 614.87 Thousand | - |
| Change in working capital | 1.14 Million | 709.57 Thousand | 555.95 Thousand | -811.09 Thousand | 101.24 Thousand | 374.44 Thousand |
| Other non-cash items | 10.29 Million | -1.00 | -30.00 | 2.21 Million | 694.02 Thousand | -250.34 Thousand |
| Investing Cash Flow | -64.91 Thousand | -241.2 Thousand | -1 Million | -1.33 Million | -5365.00 | -154.91 Thousand |
| Investments in PPE | -64.91 Thousand | -241.2 Thousand | -1 Million | -1.33 Million | -5365.00 | -154.91 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -64.91 Thousand | - | -975 Thousand | -150 Thousand | - | - |
| Financing Cash Flow | 16.72 Million | 13.59 Million | 10.12 Million | 10 Million | 2.45 Million | 1.14 Million |
| Debt repayment | - | - | - | -840 Thousand | -76 Thousand | -1.14 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 247.98 Thousand | - | - | - | - | - |
| Common Stock Issuance | 16.72 Million | 13.59 Million | 10.12 Million | 10.76 Million | 489.00 | - |
| Other Financing Activities | 16.72 Million | 13.59 Million | 10.12 Million | 79.02 Thousand | 2.52 Million | - |
| Accounts receivables | -364.99 Thousand | - | - | - | - | - |
| Accounts payables | 1.79 Million | 214.13 Thousand | 266.21 Thousand | -59.03 Thousand | -15.63 Thousand | 233.2 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -288.3 Thousand | 495.43 Thousand | 289.73 Thousand | -752.06 Thousand | 116.87 Thousand | 141.23 Thousand |
| Cash at beginning of period | 10.46 Million | 5.53 Million | 5.58 Million | 2.31 Million | 922.1 Thousand | 235.88 Thousand |
| Cash at end of period | 13.58 Million | 10.46 Million | 5.53 Million | 5.58 Million | 2.31 Million | 922.1 Thousand |
| Capital Expenditure | -64.91 Thousand | -241.2 Thousand | -1 Million | -1.33 Million | -5365.00 | -154.91 Thousand |
| Effect of forex changes on cash | -1.76 Million | - | - | - | - | - |
| Net cash flow / Change in cash | 3.12 Million | 4.93 Million | -51.03 Thousand | 3.26 Million | 1.39 Million | 686.22 Thousand |
| Free Cash Flow | -13.6 Million | -8.66 Million | -10.17 Million | -6.73 Million | -1.05 Million | -461.78 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.53 Million | -3.5 Million | -13.74 Million | -3.65 Million | -995.66 Thousand | -5.23 Million |
| Depreciation & Amortization | 106.84 Thousand | 105.89 Thousand | 412.33 Thousand | 105.04 Thousand | 103.1 Thousand | 101.68 Thousand |
| Deferred income taxes | - | - | -13.2 Million | 66.91 Thousand | - | - |
| Stock-based compensation | 283.59 Thousand | 294.89 Thousand | 1.55 Million | 400.28 Thousand | 375.23 Thousand | 415.12 Thousand |
| Change in working capital | 294.25 Thousand | -627.61 Thousand | 1.14 Million | -57.48 Thousand | 1.42 Million | -726.73 Thousand |
| Other non-cash items | 176.17 Thousand | 1.36 Million | 10.29 Million | 27.42 Thousand | -2.56 Million | -439.61 Thousand |
| Investing Cash Flow | - | -11.38 Thousand | -64.91 Thousand | -24.14 Thousand | -3356.00 | -22.61 Thousand |
| Investments in PPE | 3.00 | -11.38 Thousand | -64.91 Thousand | -24.14 Thousand | -3356.00 | -22.61 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -11.38 Thousand | -64.91 Thousand | -64.91 Thousand | - | - |
| Financing Cash Flow | 55.63 Thousand | 150.7 Thousand | 16.72 Million | 1.84 Million | -556.92 Thousand | 15.28 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | 145.95 Thousand | 247.98 Thousand | 247.98 Thousand | -33.56 Thousand | - |
| Common Stock Issuance | 55.63 Thousand | 150.7 Thousand | 16.72 Million | 1.84 Million | -556.92 Thousand | 15.28 Million |
| Other Financing Activities | 55.63 Thousand | -145.95 Thousand | 16.72 Million | 1.84 Million | -523.36 Thousand | 15.28 Million |
| Accounts receivables | 1260.00 | 364.99 Thousand | -364.99 Thousand | -364.99 Thousand | - | - |
| Accounts payables | 346.73 Thousand | -1.14 Million | 1.79 Million | 677.27 Thousand | 329.76 Thousand | 275.3 Thousand |
| Inventory | - | - | - | -1.43 Million | - | - |
| Other working capital | -52.47 Thousand | 148.34 Thousand | -288.3 Thousand | 1.06 Million | 1.09 Million | -1 Million |
| Cash at beginning of period | 10.07 Million | 13.58 Million | 10.46 Million | 14.87 Million | 17.09 Million | 7.71 Million |
| Cash at end of period | 7.3 Million | 10.07 Million | 13.58 Million | 13.58 Million | 14.87 Million | 17.09 Million |
| Capital Expenditure | 3.00 | -11.38 Thousand | -64.91 Thousand | -24.14 Thousand | -3356.00 | -22.61 Thousand |
| Effect of forex changes on cash | - | - | -1.76 Million | -13.54 Million | -1.00 | 1.00 |
| Net cash flow / Change in cash | -2.77 Million | -3.51 Million | 3.12 Million | -1.28 Million | -2.22 Million | 9.37 Million |
| Free Cash Flow | -2.82 Million | -3.66 Million | -13.6 Million | -3.13 Million | -1.66 Million | -5.9 Million |
300554
IBRX
NVEC
KKCL
300966
4845